Cystatin C predicts mortality in patients with coronary artery disease both among subjects with and among those without the metabolic syndrome

1 September 2025 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Cardiovascular risk assessment: biomarkers (3) Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by